Alcista
$68.96
Precio del escenario
$71.850
-0.424 (-0.59%)Al cierre
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $71.85 and an impressive gross margin of 100%. The company reported a Q2 2026 EPS of $0.60, beating expectations by $0.05, and has raised its revenue guidance for fiscal 2026, anticipating a growth of 9% to 10%. However, the main risk is the forward P/E ratio of 31.55, indicating that the stock may be overvalued if growth does not meet expectations.
UBS
$72
2026-07-31
UBS
2026-07-31
Precio objetivo
$72
JPMorgan
$90
2026-07-31
JPMorgan
2026-07-31
Precio objetivo
$90
JPMorgan
$80
2026-05-15
JPMorgan
2026-05-15
Precio objetivo
$80
UBS
$75
2026-05-01
UBS
2026-05-01
Precio objetivo
$75
JPMorgan
$95
2026-03-26
JPMorgan
2026-03-26
Precio objetivo
$95
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

H&MV Engineering Secures €750 Million Investment for U.S. Expansion

Exponent Reports Strong Q2 2026 Earnings Growth Driven by AI Demand

Exponent Q2 Earnings Exceed Expectations

CEO Catherine Corrigan Sells Shares of Exponent, Inc.

Exponent CEO's Stock Sale Raises Eyebrows
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).
Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $71.85 and an impressive gross margin of 100%. The company reported a Q2 2026 EPS of $0.60, beating expectations by $0.05, and has raised its revenue guidance for fiscal 2026, anticipating a growth of 9% to 10%. However, the main risk is the forward P/E ratio of 31.55, indicating that the stock may be overvalued if growth does not meet expectations.
4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.